Procalcitonin--a novel biochemical marker for the mediator-directed therapy of sepsis.

Suppr

超能文献

作者信息

Russwurm S, Oberhoffer M, Zipfel P F, Reinhart K

出版信息

Mol Med Today. 1999 Jul;5(7):286-7. doi: 10.1016/s1357-4310(99)01505-1.

DOI:10.1016/s1357-4310(99)01505-1

PMID:10377518

Abstract

摘要

相似文献

Procalcitonin--a novel biochemical marker for the mediator-directed therapy of sepsis.

Mol Med Today. 1999 Jul;5(7):286-7. doi: 10.1016/s1357-4310(99)01505-1.

Procalcitonin: new insights on regulation and origin.

Crit Care Med. 2000 Feb;28(2):586-8. doi: 10.1097/00003246-200002000-00058.

Biomarkers in the critically ill patient: procalcitonin.

Crit Care Clin. 2011 Apr;27(2):253-63. doi: 10.1016/j.ccc.2011.01.002.

Procalcitonin: THE marker of sepsis?

Crit Care Med. 2000 Apr;28(4):1226-8. doi: 10.1097/00003246-200004000-00057.

Procalcitonin-a new marker of severe infection and sepsis.

Intensive Care Med. 2000 Mar;26 Suppl 2:S145. doi: 10.1007/BF02900726.

[Procalcitonin--a specific marker for severe bacterial infection and sepsis].

Harefuah. 2001 Apr;140(4):343-6.

Procalcitonin as a marker of sepsis.

Int J Antimicrob Agents. 2002 Jul;20(1):1-9. doi: 10.1016/s0924-8579(02)00047-x.

Procalcitonin Is Not a Useful Biomarker of Sepsis.

Ann Emerg Med. 2015 Sep;66(3):320-1. doi: 10.1016/j.annemergmed.2015.03.010.

Molecular aspects and natural source of procalcitonin.

Clin Chem Lab Med. 1999 Aug;37(8):789-97. doi: 10.1515/CCLM.1999.119.

Procalcitonin: how a hormone became a marker and mediator of sepsis.

Swiss Med Wkly. 2001 Oct 20;131(41-42):595-602. doi: 10.4414/smw.2001.09751.

引用本文的文献

Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients.

Clin Chim Acta. 2020 Nov;510:181-185. doi: 10.1016/j.cca.2020.07.024. Epub 2020 Jul 15.

Diagnostic markers for community-acquired pneumonia.

Ann Transl Med. 2020 May;8(9):609. doi: 10.21037/atm.2020.02.182.

Procalcitonin as a biomarker in equine chronic pneumopathies.

BMC Vet Res. 2016 Dec 9;12(1):281. doi: 10.1186/s12917-016-0912-4.

Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases.

J Korean Med Sci. 2011 Sep;26(9):1147-51. doi: 10.3346/jkms.2011.26.9.1147. Epub 2011 Sep 1.

Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis.

Langenbecks Arch Surg. 2003 Jul;388(3):181-8. doi: 10.1007/s00423-003-0390-6. Epub 2003 Jul 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Procalcitonin--a novel biochemical marker for the mediator-directed therapy of sepsis.

Mol Med Today. 1999 Jul;5(7):286-7. doi: 10.1016/s1357-4310(99)01505-1.

Procalcitonin: new insights on regulation and origin.

Crit Care Med. 2000 Feb;28(2):586-8. doi: 10.1097/00003246-200002000-00058.

Biomarkers in the critically ill patient: procalcitonin.

Crit Care Clin. 2011 Apr;27(2):253-63. doi: 10.1016/j.ccc.2011.01.002.

Procalcitonin: THE marker of sepsis?

Crit Care Med. 2000 Apr;28(4):1226-8. doi: 10.1097/00003246-200004000-00057.

Procalcitonin-a new marker of severe infection and sepsis.

Intensive Care Med. 2000 Mar;26 Suppl 2:S145. doi: 10.1007/BF02900726.

[Procalcitonin--a specific marker for severe bacterial infection and sepsis].

Harefuah. 2001 Apr;140(4):343-6.

Procalcitonin as a marker of sepsis.

Int J Antimicrob Agents. 2002 Jul;20(1):1-9. doi: 10.1016/s0924-8579(02)00047-x.

Procalcitonin Is Not a Useful Biomarker of Sepsis.

Ann Emerg Med. 2015 Sep;66(3):320-1. doi: 10.1016/j.annemergmed.2015.03.010.

Molecular aspects and natural source of procalcitonin.

Clin Chem Lab Med. 1999 Aug;37(8):789-97. doi: 10.1515/CCLM.1999.119.

Procalcitonin: how a hormone became a marker and mediator of sepsis.

Swiss Med Wkly. 2001 Oct 20;131(41-42):595-602. doi: 10.4414/smw.2001.09751.

引用本文的文献

Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients.

Clin Chim Acta. 2020 Nov;510:181-185. doi: 10.1016/j.cca.2020.07.024. Epub 2020 Jul 15.

Diagnostic markers for community-acquired pneumonia.

Ann Transl Med. 2020 May;8(9):609. doi: 10.21037/atm.2020.02.182.

Procalcitonin as a biomarker in equine chronic pneumopathies.

BMC Vet Res. 2016 Dec 9;12(1):281. doi: 10.1186/s12917-016-0912-4.

Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases.

J Korean Med Sci. 2011 Sep;26(9):1147-51. doi: 10.3346/jkms.2011.26.9.1147. Epub 2011 Sep 1.

Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis.

Langenbecks Arch Surg. 2003 Jul;388(3):181-8. doi: 10.1007/s00423-003-0390-6. Epub 2003 Jul 11.